Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Other hematologic neoplasm 2Myeloid 2Lymphoid 2

Conditions

Myelodysplastic Syndromes 26Leukemia, Myeloid, Acute 24Lymphoma, Non-Hodgkin 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Leukemia 19Leukemia, Myelogenous, Chronic, BCR-ABL Positive 17Hodgkin Disease 16Hematologic Neoplasms 16Lymphoma 14Leukemia, Lymphocytic, Chronic, B-Cell 14Multiple Myeloma 11Myeloproliferative Disorders 10Graft vs Host Disease 9Primary Myelofibrosis 8Leukemia, Myelomonocytic, Juvenile 8Lymphoma, Mantle-Cell 7Lymphoma, Large B-Cell, Diffuse 7Lymphoma, Follicular 7Lymphoma, B-Cell, Marginal Zone 6Leukemia, Myelomonocytic, Chronic 6Neoplasms 5Lymphoma, Large-Cell, Immunoblastic 5Leukemia, Myeloid, Accelerated Phase 5Burkitt Lymphoma 5Anemia, Refractory, with Excess of Blasts 5Leukemia, Myeloid, Chronic-Phase 4Congenital Abnormalities 4Blast Crisis 4Waldenstrom Macroglobulinemia 3Neuroblastoma 3

Interventions

Cytarabine 3Cyclophosphamide 3thymoglobulin 2fludarabine phosphate 2fludarabine 2Thiotepa 2Tacrolimus 2Rituximab 2Melphalan 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2vosaroxin 1plerixafor 1devimistat 1blinatumomab 1aldesleukin 1Transplantation 1Sirolimus 1Razoxane 1Mycophenolic Acid 1Metformin 1Mesna 1Interleukin-2 1Idarubicin 1Gemtuzumab 1Dexrazoxane 1Clofarabine 1Cladribine 1Busulfan 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Sarcoma, Myeloid × thymoglobulin × Clear all
NCT02790515 2025-08-12

Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
170 enrolled
LymphoidMyeloidOther hematologic neoplasmSarcoma

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Sarcoma, Myeloid, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

NCT01621477 2017-02-20

T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant

St. Jude Children's Research Hospital

Phase 2 Terminated
34 enrolled 12 charts
LymphoidMyeloidOther hematologic neoplasmSarcoma

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Sarcoma, Myeloid, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡